Advert - Sunovion
-
Date posted01 November 2017
-
SanctionAdvertisement,
-
Case number/s
For one of its managers encouraging staff at a regional sales meeting to suggest to customers that if they did not consider Latuda (lurasidone) as part of a patient review there might be legal consequences, Sunovion was ruled in breach of the following clauses of the Code:
Clause 15.2 - Failing to maintain a high standard of ethical conduct in the field force.
Clause 15.9 - Providing verbal direction that advocated a course of action which would be likely to lead to a breach of the Code.
The Code of Practice Appeal Board subsequently publicly reprimanded Sunovion for providing inaccurate and misleading information to the Panel and the Appeal Board. The Appeal Board considered that self-regulation relied, inter alia, upon the provision of complete and accurate information. The Appeal Board also required Sunovion to be audited. The interim case report is available at www.pmcpa.org.uk.